CellCarta and Imagene AI Expand AI-Powered Diagnostic Programs

This collaboration advances AI in healthcare diagnostics, potentially improving drug development efficacy and patient outcomes.

Auto-scored: The event is a benign business expansion in medical AI with no identified risks and represents a real but partial mitigation step.